Instrument Inactif

Communiqués AIT Therapeutics Inc Other OTC

Actions

US50027L1070

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

25/06	Mise à jour sectorielle : Les actions du secteur de la santé ralentissent en fin d'après-midi	MT
25/06	Mise à jour sectorielle : Soins de santé	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Beyond Air : Corporate Presentation	24/06	PU
Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update	24/06	AQ
Beyond Air® Appoints David Webster as Chief Commercial Officer	13/06	AQ
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)	03/06	AQ
Beyond Air : Corporate Presentation	31/05	PU
Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast	23/05	AQ
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting	01/05	AQ
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants	20/03	AQ
Beyond Air : Corporate Presentation	13/03	PU
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024	12/02	AQ
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast	18/01	AQ
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors	27/12	AQ
Thinking about buying stock in Polished.Com, Mereo BioPharma, Fusion Pharmaceuticals, Luminar Technologies, or Beyond Air?	20/12	PR
Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference	15/11	AQ
Thinking about buying stock in Invo Bioscience, Singing Machine Company, Beauty Health, Beyond Air, or Tivic Health Systems?	14/11	PR
Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024	13/11	AQ
Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting	03/11	AQ
Beyond Air : Corporate Presentation	30/10/23	PU
Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast	19/10/23	AQ
Beyond Air® To Participate in the Truist Securities BioPharma Symposium	17/10/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués AIT Therapeutics Inc Other OTC

Actions

US50027L1070

Communiqués

Filtres